<SEC-DOCUMENT>0001104659-21-009098-index.html : 20210129 <SEC-HEADER>0001104659-21-009098.hdr.sgml : 20210129 <ACCEPTANCE-DATETIME>20210129090703 ACCESSION NUMBER: 0001104659-21-009098 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20210129 DATE AS OF CHANGE: 20210129 GROUP MEMBERS: NOVARTIS AG SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Annexon, Inc. CENTRAL INDEX KEY: 0001528115 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 275414423 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-91583 FILM NUMBER: 21568376 BUSINESS ADDRESS: STREET 1: 180 KIMBALL WAY STREET 2: SUITE 200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650)-822-5500 MAIL ADDRESS: STREET 1: 180 KIMBALL WAY STREET 2: SUITE 200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Novartis Bioventures Ltd CENTRAL INDEX KEY: 0001297709 IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: C/O NOVARTIS INTERNATIONAL AG STREET 2: WSJ-200.220 CITY: CH-4002 BASEL STATE: V8 ZIP: 0000000000 BUSINESS PHONE: 41-61-324-6210 MAIL ADDRESS: STREET 1: C/O NOVARTIS INTERNATIONAL AG STREET 2: WSJ-200.220 CITY: CH-4002 BASEL STATE: V8 ZIP: 0000000000 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13G <SEQUENCE>1 <FILENAME>tm214547d1_sc13g.htm <DESCRIPTION>SC 13G <TEXT> Document 1 - file: tm214547d1_sc13g.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>tm214547d1_ex99-1.htm <DESCRIPTION>EXHIBIT 99.1 <TEXT> Document 2 - file: tm214547d1_ex99-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>3 <FILENAME>tm214547d1_ex99-2.htm <DESCRIPTION>EXHIBIT 99.2 <TEXT> Document 3 - file: tm214547d1_ex99-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.3 <SEQUENCE>4 <FILENAME>tm214547d1_ex99-3.htm <DESCRIPTION>EXHIBIT 99.3 <TEXT> Document 4 - file: tm214547d1_ex99-3.htm
</DOCUMENT> </SEC-DOCUMENT>